MAGRIT: The Largest-Ever Phase III Lung Cancer Trial Aims to Establish a Novel Tumor-Specific Approach to Therapy
Year: 2009
Type: article
Study design: Study Protocol
Source: Clinical Lung Cancer
Authors: Preeta Tyagi, Beloo Mirakhur
Institution: GlaxoSmithKline (United States)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2029744149
